• 1
    Clyne W, Blenkinsopp A, Seal R. A Guide to Medication Review. 2008. Available at (last accessed November 2011).
  • 2
    American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model. 2008. Available at (last accessed November 2011).
  • 3
    Ontario Ministry of Health and Long-Term Care. MedsCheck. 2011. Availabe at (last accessed September 2012).
  • 4
    Australia Government, Department of Human Services. Home Medicines Review (HMR). 2012. Available at (last accessed August 2010).
  • 5
    Pharmacy Council of New Zealand. Medicines management: definition, levels, competence framework. 2006. Available at (last accessed August 2011).
  • 6
    NHS Cumbria Medicine Management Team. Clinical medication review: a practice guide. 2011. Available at (last accessed May 2012).
  • 7
    Lee E, Braund R, Tordoff J. Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand, 2008. N Z Med J 2009; 122: 2635.
  • 8
    McCann L, Hughes CM, Adair CG. A self-reported work-sampling study in community pharmacy practice: a 2009 update. Pharm World Sci 2010; 32: 536543.
  • 9
    Young S, Duffull SB. A learning-based approach for performing an in-depth literature search using MEDLINE. J Clin Pharm Ther 2011; 36: 504512.
  • 10
    Higgins J , Green S , eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated March 2011]. The Cochrane Collaboration, 2011. Available at (last accessed September 2012).
  • 11
    Reeves BC, Deeks JJ, Higgins JPT, Wells GA. Chapter 13: including non-randomzed studies. Cochrane Handbook for Systematic Reviews Interventions. Version 5.0.1 [updated September 2008]. 2008. Available at: (last accessed February 2013).
  • 12
    Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. Chichester: John Wiley & Sons, Ltd, 2009.
  • 13
    Koshman SL, Scot HS, Ross TT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med 2008; 168: 687694.
  • 14
    Chisholm-Burns MA, Jeannie KL, Spivey CA, Slack M, Herrier RN, Hall-Lipsy E, Graff Zivin J, Abraham I, Palmer J, Martin JR, Kramer S, Wun T. US Pharmacists' Effect as Team Members on Patient Care Systematic Review and Meta-Analyses. Med Care 2010; 48: 923933.
  • 15
    Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB, Brown LM, Cipolle RJ. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc 2008; 48: 203211.
  • 16
    Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, Shepstone L, Lipp A, Daly C, Howe A, Hall R, Harvey I. Effectiveness of visits from community pharmacists for patients with heart failure: heartMed randomised controlled trial. BMJ 2007; 334: 10981101.
  • 17
    Machado M, Bajcar J, Guzzo G, Einarson T. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007; 41: 17701781.
  • 18
    Charrois TL, Zolezzi M, Koshman SL, Pearson G, Makowsky M, Durec T, Tsuyuki RT. A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy 2012; 32: 222233.
  • 19
    Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2007; 65: 303316.
  • 20
    Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc (Wash) 1996; NS36 (Jul): 443451.
  • 21
    Munroe WP, Kunz K, Dalmady-Israel C, Potter L, Schonfeld WH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997; 19: 113123.
  • 22
    Begley S, Livingstone C, Hodges N, Williamson V. Impact of domiciliary pharmacy visits on medication management in an elderly population. Int J Pharm Prac 1997; 5: 111121.
  • 23
    Carter BL, Barnette DJ, Chrischilles E, Mazzotti GJ, Asali ZJ. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy 1997; 17: 12741285.
  • 24
    Anonymous. Impact of pharmaceutical care delivered in the community pharmacy setting: results of a two year demonstration project. Iowa Pharm 2000; 55 (Jan-Feb): 1824.
  • 25
    Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy 2001; 21 (10 I): 11961203.
  • 26
    Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler CD, Grainger-Rousseau T, Ersboell BK. Improving drug therapy for patients with asthma. Part 1. Patient outcomes. J Am Pharm Assoc (Wash) 2001; 41 (Jul-Aug): 539550.
  • 27
    Herborg H, Soendergaard B, Jorgensen T, Fonnesbaek L, Hepler CD, Holst H, Froekjaer B. Improving drug therapy for patients with asthma-part 2: use of antiasthma medications. J Am Pharm Assoc (Wash) 2001; 41: 551559.
  • 28
    Schulz M, Verheyen F, Mühlig S, Ller JM, Hlbauer K, Knop-Schneickert E, Petermann F, Bergmann KC. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol 2001; 41: 668676.
  • 29
    Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, Bero LA. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm 2002; 59: 15181526.
  • 30
    Fischer LR, Defor TA, Cooper S, Scott LM, Boonstra DM, Eelkema MA, Goodman MJ. Pharmaceutical care and health care utilization in an HMO. Eff Clin Pract 2002; 5: 4957.
  • 31
    Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm 2003; 60: 11231129.
  • 32
    Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 2003; 25: 218226.
  • 33
    Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, Goeree R, Cosby R, Trim K, Sebaldt R, Howard M, Hardcastle L, Poston J. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J 2003; 169: 1722.
  • 34
    Chabot I, Moisan J, Gregoire JP, Milot A. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003; 37: 11861193.
  • 35
    Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoe AW, Leufkens HGM. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a Randomized Controlled Study. J Card Fail 2003; 9: 404411.
  • 36
    Chrischilles EA, Carter BL, Lund BC, Rubenstein LM, Chen-Hardee SS, Voelker MD, Park TR, Kuehl AK. Evaluation of the Iowa Medicaid pharmaceutical case management program. JAPhA 2004; 44: 337349.
  • 37
    Krass I, Taylor SJ, Smith C, Armour CL. Impact on medication use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc 2005; 45: 3340.
  • 38
    Paulos CP, Akesson Nygren CE, Celedon C, Carcamo CA. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. Ann Pharmacother 2005; 39: 939943.
  • 39
    Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy 2005; 25: 96109.
  • 40
    Vrijens B, Belmans A, Matthys K, de Klerk E, Lesaffre E, Vrijens B, Belmans A, Matthys K, de Klerk E, Lesaffre E. Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. Pharmacoepidemiol Drug Saf 2006; 15: 115121.
  • 41
    Christensen DB, Roth M, Trygstad T, Byrd J. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan. J Am Pharm Assoc 2007; 47: 471483.
  • 42
    Scott A, Tinelli M, Bond C. Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England – Healthcare system and patient perspectives. Pharmacoeconomics 2007; 25: 397411.
  • 43
    Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, Saini B, Smith L, Stewart K. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007; 62: 496502.
  • 44
    Lenaghan E, Holland R, Brooks A, Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care–the POLYMED randomised controlled trial. Age Ageing 2007; 36: 292297.
  • 45
    Community Pharmacy Medicines Management Project Evaluation Team. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract 2007; 24: 189200.
  • 46
    Saini B, Filipovska J, Bosnic-Anticevich S, Taylor S, Krass I, Armour C. An evaluation of a community pharmacy-based rural asthma management service. Aust J Rural Health 2008; 16: 100108.
  • 47
    Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Brusselle G. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J 2008; 31: 790799.
  • 48
    Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. JAPhA 2009; 49: 164170.
  • 49
    Hugtenburg JG, Borgsteede SD, Beckeringh JJ. Medication review and patient counselling at discharge from the hospital by community pharmacists. Pharm World Sci 2009; 31: 630637.
  • 50
    Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP, Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries. J Manag Care Pharm 2009; 15: 3241.
  • 51
    Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, Killer G, Gilbert AL. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail 2009; 2: 424428.
  • 52
    Hohmann C, Klotz JM, Radziwill R, Jacobs AH, Kissel T. Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life. Pharm World Sci 2009; 31: 550558.
  • 53
    Villeneuve J, Genest J, Blais L, Vanier MC, Lamarre D, Fredette M, Lussier MT, Perreault S, Hudon E, Berbiche D, Lalonde L. A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study. CMAJ 2010; 182: 447455.